| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Jan 7, 2025 | Intellia Therapeutics, Inc. | EVP, Chief Business Officer | Sell | 42.5 | -6,502 | -9.80% | ✗ | $79.2K |
| Jan 3, 2024 | Jan 5, 2024 | Intellia Therapeutics, Inc. | EVP, Chief Business Officer | Sell | 42.5 | -3,877 | -9.49% | ✗ | $114.2K |
| Jan 4, 2023 | Jan 6, 2023 | Intellia Therapeutics, Inc. | EVP, Chief Business Officer | Sell | 42.5 | -1,812 | -9.48% | ✗ | $67.4K |